UPI Share Price

Open 1.26 Change Price %
High 1.29 1 Day -0.03 -2.40
Low 1.18 1 Week 0.00 0.00
Close 1.22 1 Month 0.00 0.00
Volume 236637 1 Year 0.00 0.00
52 Week High 1.81
52 Week Low 0.36
UPI Important Levels
Resistance 2 1.32
Resistance 1 1.28
Pivot 1.23
Support 1 1.16
Support 2 1.12
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.24 -11.11%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
ORCL 50.30 8.57%
ORCL 50.30 8.57%
ORCL 50.30 8.57%
RFMD 16.59 -2.07%
More..
NASDAQ USA Top Gainers Stocks
GCFB 0.95 58.33%
FALC 0.38 52.00%
LOCM 0.09 50.00%
ENOC 7.65 41.67%
TROV 1.30 36.84%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
AMRS 3.29 21.40%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
PTSX 0.12 -40.00%
More..

Uroplasty, Inc. (NASDAQ: UPI)

UPI Technical Analysis 5
As on 31st Mar 2015 UPI Share Price closed @ 1.22 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.30 & Strong Sell for SHORT-TERM with Stoploss of 1.28 we also expect STOCK to react on Following IMPORTANT LEVELS.
UPI Target for June
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
UPI Other Details
Segment EQ
Market Capital 73255040.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.uroplasty.com
UPI Address
UPI
5420 Feltl Road
Minnetonka, MN 55343
United States
Phone: 952-426-6140
Fax: 952-426-6199
UPI Latest News
Interactive Technical Analysis Chart Uroplasty, Inc. ( UPI NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Uroplasty, Inc.
UPI Business Profile
Uroplasty, Inc. is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. The Company�s primary focus is on two products: the Urgent PC Neuromodulation system and Macroplastique Implants. The Urgent PC system is a United States Food and Drug Administration (FDA)-approved minimally invasive, office-based neuromodulation therapy for the treatment of overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency, and urge incontinence; and Macroplastique Implants a urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency (ISD). Outside of the United States, the Company�s Urgent PC is also approved for treatment of fecal incontinence, and Macroplastique is also approved for treatment of male stress incontinence and vesicoureteral reflux.